BTAI Up 105% In 5 Days, NVAX Gets A Shot In The Arm, BMY Snaps Up CELG

Today's Daily Dose brings you news about this year's first, and one of the biggest pharmaceuticals deals; BioXcel Therapeutics' Alzheimer's study results; CAS Medical's preliminary unaudited Q4 sales results; Catabasis Pharma's update on DMD trial; Marker Therapeutics' pipeline progress; and Novavax' phase II clinical trial results of NanoFlu.

from RTT - Biotech http://bit.ly/2VsI4A7
via IFTTT